Publication | Closed Access

Repurposing of Secukinumab as Neuroprotective in Cuprizone-Induced Multiple Sclerosis Experimental Model via Inhibition of Oxidative, Inflammatory, and Neurodegenerative Signaling

InflammationCytokineNeurodegenerative DiseasesMedicineImmunologyCell DeathNeurodegenerative SignalingAutoimmunityBrain-immune InteractionNeuroprotectionMultiple SclerosisNeuroimmunologyPharmacologyCell BiologyCell SignalingNeuroinflammation